The ICMR has formalized a Memorandum of Agreement (MoA) with Zydus for a Phase IIa double-blind, randomized, placebo-controlled study to assess the efficacy and safety of the oral tablet Desidustat for treating sickle cell disease, a genetic blood disorder marked by abnormal hemoglobin (Hb).
With northern hemisphere countries hit by a pandemic winter surge, Britain this week became the first Western country to roll out the Pfizer-BioNTech vaccine.
West Bengal Governor Jagdeep Dhankhar said NICED has been chosen as one among two dozen centres in the country for the third phase trial of the indigenously developed coronavirus vaccine.